Literature DB >> 29163697

Reoperation following the use of non-standardized procedures for malignant parotid tumors.

Xiangmin Zhang1, Xiangfu Zeng2, Xiaolin Lan1, Jing Huang3, Keqing Luo1, Keqiang Tian1, Xiuhong Wu4, Fufu Xiao1, Shaojin Li3.   

Abstract

Non-standardized or conservative procedures are employed when parotid tumors involving the facial nerve or parotid carcinoma are misdiagnosed as benign parotid tumors prior to or during surgery. Remedial measures are usually required when the pathological diagnosis of a malignant parotid tumor is confirmed following surgery. The aim of the present study was to systematically evaluate reoperation subsequent to treatment with non-standardized procedures for malignant parotid tumors, and to explore the preoperative diagnoses, the primary procedure selection and the necessity of reoperation following non-standardized procedures in malignant parotid tumors. A total of 30 patients who met the inclusion criteria, were diagnosed with a malignant parotid tumor and underwent reoperation following the use of a non-standardized procedure were included in the present study. Surgical conditions and clinical data were analyzed. Among the patients with a malignant parotid tumor who underwent reoperation subsequent to a non-standardized procedure, the incidence of residual tumor, as confirmed by pathological examination, was 63.3% (19/30). The intact facial nerve preservation rate was 83.3% (25/30), the facial nerve branch resection rate was 6.7% (2/30), the facial partial nerve resection rate was 6.7% (2/30) and the facial nerve resection rate was 3.3% (1/30). In total, 3 patients underwent facial nerve reconstruction, 3 patients underwent a local flap repair of skin defects in the parotid region and 3 patients underwent pectoralis major muscle flap repair. The current findings indicate that the qualitative diagnosis of malignant parotid tumors prior to surgery is difficult, there is a high incidence of residual tumor following non-standardized procedures, and that reoperation in a timely manner is required in such cases.

Entities:  

Keywords:  malignancy; parotid tumor; reoperation

Year:  2017        PMID: 29163697      PMCID: PMC5686523          DOI: 10.3892/ol.2017.7020

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  50 in total

1.  Free vascularized lateral femoral cutaneous nerve graft with anterolateral thigh flap for reconstruction of facial nerve defects.

Authors:  Takuya Iida; Masahiro Nakagawa; Takayuki Asano; Chihiro Fukushima; Kazuhumi Tachi
Journal:  J Reconstr Microsurg       Date:  2006-07       Impact factor: 2.873

2.  Navigation-guided resection with immediate functional reconstruction for high-grade malignant parotid tumour at skull base.

Authors:  P J Voss; A M Leow; D Schulze; M C Metzger; N Liebehenschel; R Schmelzeisen
Journal:  Int J Oral Maxillofac Surg       Date:  2009-05-26       Impact factor: 2.789

3.  Assessing the histological type and grade of primary parotid carcinoma by fine-needle aspiration and frozen section.

Authors:  Shuji Nishikawa; Ryo Kawata; Masaaki Higashino; Koutetsu Lee; Tetsuya Terada; Yoshitaka Kurisu; Motomu Tsuji
Journal:  Auris Nasus Larynx       Date:  2015-06-09       Impact factor: 1.863

4.  [Parotid gland cancer treatment with facial nerve preservation].

Authors:  Yoshifumi Fujita; Akira Kubota; Madoka Furukawa; Hiroaki Yagi; Mamoru Tsukuda
Journal:  Nihon Jibiinkoka Gakkai Kaiho       Date:  2010-03

5.  Clinical prognostic factors in malignant parotid gland tumors.

Authors:  Roberto A Lima; Marcos R Tavares; Fernando L Dias; Jacob Kligerman; Marilene F Nascimento; Mauro M Barbosa; Claudio R Cernea; Jose R Soares; Izabella C Santos; Scheylla Salviano
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

6.  Study of salivary gland lesions with fine needle aspiration cytology and histopothology along with immunohistochemistry.

Authors:  Srabani Chakrabarti; Moumita Bera; Pranab Kumar Bhattacharya; Debasish Chakrabarty; Asim Kumar Manna; Swapan Pathak; Krishnendu Maiti
Journal:  J Indian Med Assoc       Date:  2010-12

7.  Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.

Authors:  Christopher L Ellington; Michael Goodman; Scott A Kono; William Grist; Trad Wadsworth; Amy Y Chen; Taofeek Owonikoko; Suresh Ramalingam; Dong M Shin; Fadlo R Khuri; Jonathan J Beitler; Nabil F Saba
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

8.  [Diagnostic value of needle biopsy and frozen section histological examination in the surgery of primary parotid tumors].

Authors:  M Longuet; E Nallet; C Guedon; J Depondt; P Gehanno; B Barry
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2001

Review 9.  [Salivary gland tumors. Clinical aspects and therapy].

Authors:  H Swoboda; P Franz
Journal:  Radiologe       Date:  1994-05       Impact factor: 0.635

10.  Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005.

Authors:  S A Bhide; A Miah; Y Barbachano; K J Harrington; K Newbold; C M Nutting
Journal:  Br J Oral Maxillofac Surg       Date:  2009-02-04       Impact factor: 1.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.